Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $4.37 Million - $4.98 Million
27,368 Added 1710.5%
28,968 $5.28 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $220,160 - $247,952
1,600 New
1,600 $247,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $516,788 - $643,110
3,900 New
3,900 $525,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $5.42 Million - $6.22 Million
-40,400 Reduced 56.11%
31,600 $4.24 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $7.32 Million - $9.31 Million
53,200 Added 282.98%
72,000 $11 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $13,197 - $16,375
100 Added 0.53%
18,800 $3.05 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.49 Million - $1.69 Million
14,000 Added 297.87%
18,700 $2.02 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $1.19 Million - $1.32 Million
-11,300 Reduced 70.63%
4,700 $529,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $797,940 - $878,436
7,800 Added 95.12%
16,000 $1.73 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $2.73 Million - $3.21 Million
-31,800 Reduced 79.5%
8,200 $719,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $1.76 Million - $2.36 Million
24,000 Added 150.0%
40,000 $3.93 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $1.14 Million - $1.73 Million
-17,700 Reduced 52.52%
16,000 $1.22 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.8 Million - $2.25 Million
24,900 Added 282.95%
33,700 $2.98 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $2.94 Million - $3.76 Million
-44,800 Reduced 83.58%
8,800 $640,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $4.13 Million - $4.87 Million
53,600 New
53,600 $4.32 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $3.22 Million - $3.97 Million
-41,400 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $2.89 Million - $3.21 Million
32,500 Added 365.17%
41,400 $3.92 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $6.73 Million - $7.38 Million
-75,100 Reduced 89.4%
8,900 $861,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $5.87 Million - $7.49 Million
84,000
84,000 $7.46 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.